Eccogene Receives $50M Milestone After Elecoglipron Phase 3 Start
BOSTON and SHANGHAI — September 28, 2026 Eccogene announced that it has received a $50 million milestone payment from...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
BOSTON and SHANGHAI — September 28, 2026 Eccogene announced that it has received a $50 million milestone payment from...
TÜBINGEN, Germany — September 23, 2026 ViferaXS GmbH announced the close of a Series A financing round of up...
West Chester, Pennsylvania, September 22, 2026 DePuy Synthes, the orthopedic technology business of Johnson & Johnson, is showcasing a...
Vancouver, British Columbia, September 23, 2026 Zymeworks Inc. has completed its previously announced acquisition of Theravance Biopharma, Inc., bringing...
New York, New York, September 23, 2026 Apertura Gene Therapy announced that it will provide Lexeo Therapeutics with access...
Boston, Massachusetts, U.S., September 22, 2026 Decoy Therapeutics, Inc., a clinical-stage biotechnology company developing antiviral therapeutics, has issued a...
Düsseldorf, Germany, September 22, 2026 Bio-Techne Corporation has opened a new Customer Experience Center in Düsseldorf, Germany, creating a...
Cambridge, Massachusetts, U.S., September 21, 2026 Sensorium Therapeutics, a clinical-stage central nervous system biotechnology company, has announced positive Phase...
Pleasanton, California, U.S., September 21, 2026 Veeva Systems has introduced Veeva Falcon Router, an agentic artificial intelligence solution designed...
Germantown, Maryland, U.S., September 21, 2026 Precigen has announced that the U.S. Food and Drug Administration (FDA) has granted...
